2025 North America Autism Spectrum Disorder Treatment Revenue Opportunities Report
Description
The 2025 North America Autism Spectrum Disorder Treatment Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Autism Spectrum Disorder Treatment by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in Autism Spectrum Disorder (ASD) treatment in North America include Action Behavior Centers, The Stepping Stones Group, Hopebridge Autism Therapy Centers, and ACES ABA Therapy. Action Behavior Centers, valued at approximately $840 million, operates over 140 centers across multiple states, providing ABA therapy and other autism support services. The Stepping Stones Group has a wide footprint in 32 states, with multiple acquisitions expanding its reach in behavioral and play-based therapies for autism. Hopebridge specializes in comprehensive ABA therapy, speech, and occupational therapies, with extensive insurance partnerships to increase service access nationwide. ACES ABA is also a key market player focusing on therapy services designed for children with ASD.
North America led the global ASD treatment market in 2024 with revenue of about USD 4.71 billion, driven by a high prevalence of autism and a broad adoption of behavioral therapies such as ABA, supported by public and private insurance and innovative franchising models. The market growth is fueled by increasing awareness, government support, and investment in research and development of treatments including pharmacological therapies by major biopharmaceutical companies like Bristol-Myers Squibb and Curemark, who contribute to the ecosystem with novel therapeutic candidates. Additionally, specialized centers such as the Center for Autism & the Developing Brain collaborate with hospitals and academic institutions to deliver multidisciplinary, evidence-based care tailored to all ages.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Autism Spectrum Disorder Treatment by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in Autism Spectrum Disorder (ASD) treatment in North America include Action Behavior Centers, The Stepping Stones Group, Hopebridge Autism Therapy Centers, and ACES ABA Therapy. Action Behavior Centers, valued at approximately $840 million, operates over 140 centers across multiple states, providing ABA therapy and other autism support services. The Stepping Stones Group has a wide footprint in 32 states, with multiple acquisitions expanding its reach in behavioral and play-based therapies for autism. Hopebridge specializes in comprehensive ABA therapy, speech, and occupational therapies, with extensive insurance partnerships to increase service access nationwide. ACES ABA is also a key market player focusing on therapy services designed for children with ASD.
North America led the global ASD treatment market in 2024 with revenue of about USD 4.71 billion, driven by a high prevalence of autism and a broad adoption of behavioral therapies such as ABA, supported by public and private insurance and innovative franchising models. The market growth is fueled by increasing awareness, government support, and investment in research and development of treatments including pharmacological therapies by major biopharmaceutical companies like Bristol-Myers Squibb and Curemark, who contribute to the ecosystem with novel therapeutic candidates. Additionally, specialized centers such as the Center for Autism & the Developing Brain collaborate with hospitals and academic institutions to deliver multidisciplinary, evidence-based care tailored to all ages.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
